{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Is Elevance Health, Inc. technically bullish or bearish?
As of October 3, 2025, Elevance Health, Inc. shows a neutral technical trend with mixed indicators, including a mildly bullish weekly MACD and a bearish monthly MACD, while outperforming the S&P 500 recently but underperforming over the past year, suggesting caution in the current market.
Elevance Health Stock Hits Day High with Strong Intraday Performance
Elevance Health, Inc. has seen a significant increase in its stock price today, contrasting with the modest rise of the S&P 500. Over the past week, the company has outperformed the index. However, its long-term performance reveals challenges, with a notable decline over the past year. The company has a market cap of approximately USD 69.39 billion and strong financial metrics, including a high dividend yield and substantial institutional ownership.
Is Elevance Health, Inc. technically bullish or bearish?
As of October 3, 2025, Elevance Health, Inc. shows a neutral trend with mixed signals, underperforming the S&P 500 with year-to-date returns of -4.99% compared to 14.18%.
Is Elevance Health, Inc. technically bullish or bearish?
As of October 3, 2025, Elevance Health's technical trend is neutral with mixed signals, showing mild bullishness on weekly indicators but bearishness on monthly ones, while it has outperformed the S&P 500 recently but lags behind year-to-date.
Is Elevance Health, Inc. technically bullish or bearish?
As of September 11, 2025, Elevance Health, Inc. shows a mildly bearish trend with mixed technical indicators, underperforming the S&P 500 significantly with year-to-date and one-year returns of -14.40% and -41.47%, respectively.
Is Elevance Health, Inc. overvalued or undervalued?
As of July 31, 2025, Elevance Health, Inc. is considered overvalued with a P/E ratio of 15 compared to its peers and has underperformed the S&P 500 significantly, with year-to-date returns of -14.40% and a 1-year return of -41.47%.
Is Elevance Health, Inc. overvalued or undervalued?
As of October 1, 2023, Elevance Health, Inc. is considered an attractive investment due to its undervalued status, with a P/E ratio of 15.2, a P/B ratio of 1.8, and an ROE of 18%, all of which compare favorably against industry peers like UnitedHealth Group and Cigna Group.
Is Elevance Health, Inc. technically bullish or bearish?
As of October 1, 2023, there is not enough technical data on Elevance Health, Inc. to determine if it is bullish or bearish.
Who are in the management team of Elevance Health, Inc.?
As of March 2022, the management team of Elevance Health, Inc. includes Independent Chairman Ms. Elizabeth Tallett, CEO Ms. Gail Boudreaux, and several Independent Directors: Mr. R. Kerry Clark, Mr. Robert Dixon, Mr. Lewis Hay, Ms. Julie Hill, and Dr. Bahija Jallal. They are responsible for the company's strategic direction and governance.
What does Elevance Health, Inc. do?
Elevance Health, Inc. is a health benefits company with a market cap of approximately $84.77 billion, reporting a net profit of $2.18 billion in Q1 2025. Key metrics include a P/E ratio of 15.00 and a dividend yield of 141.81%.
How big is Elevance Health, Inc.?
As of Jun 18, Elevance Health, Inc. has a market capitalization of $84.77 billion, with net sales of $0 million and a net profit of $5.91 billion over the latest four quarters. The company reported shareholder's funds of $41.32 billion and total assets of $116.89 billion as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
